Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00342849 · ClinicalTrials.gov registry record · Phase 3
Treatment of Lead-Exposed Children Trial
A Phase 3 study, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- Phase 3
- Development phase
- 780
- Enrollment target
NCT00342849 is a Phase 3 study that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 780 participants.
The verdict
NCT00342849, a Phase 3 study, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 780 participants
- Enrollment target
Study Summary
The Treatment of Lead-Exposed Children (TLC) clinical trial compared the effect of lead chelation with succimer to placebo therapy. TLC was a randomized, double-blind, placebo-controlled clinical trial with sites in Cincinnati and Columbus, Ohio, Philadelphia, Pennsylvania, Baltimore, Maryland and Newark, New Jersey. The study was designed to test outcomes in IQ, neuropsychological function, behavior, physical growth and blood pressure three years after initiation of treatment. Enrollment was conducted between 1994 and 1997, with completion of the initial three-year follow-up in 2000.
Interventions
- DRUG Placebo
- DRUG Succimer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 780 participants |
| Start Date | 1994-07-15 |
| Est. Completion | 2015-06-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00342849
The ClinicalTrials.gov registry entry for NCT00342849 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 780 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Environmental Health Sciences (NIEHS), which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00342849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00342849 about?
NCT00342849 is a clinical study titled "Treatment of Lead-Exposed Children Trial". The Treatment of Lead-Exposed Children (TLC) clinical trial compared the effect of lead chelation with succimer to placebo therapy. TLC was a randomized, double-blind, placebo-controlled clinical trial with sites in Cincinnati and Columbus, Ohio, Philadelphia, Pennsylvania, Baltimore, Maryland and N...
What is the current status of trial NCT00342849?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 780 participants. The study started on 1994-07-15. Estimated completion is 2015-06-10.
What interventions are being tested in trial NCT00342849?
The interventions under investigation include: Placebo (DRUG), Succimer (DRUG).
Who is sponsoring clinical trial NCT00342849?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.